ATE103294T1 - Peptidfragmente von hiv. - Google Patents

Peptidfragmente von hiv.

Info

Publication number
ATE103294T1
ATE103294T1 AT90308662T AT90308662T ATE103294T1 AT E103294 T1 ATE103294 T1 AT E103294T1 AT 90308662 T AT90308662 T AT 90308662T AT 90308662 T AT90308662 T AT 90308662T AT E103294 T1 ATE103294 T1 AT E103294T1
Authority
AT
Austria
Prior art keywords
proline
hiv
peptide
isoleucine
fragment
Prior art date
Application number
AT90308662T
Other languages
English (en)
Inventor
Andrew James Mcmichael
Douglas Fraser Nixon
Alain Robert Michael Townsend
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43806939&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE103294(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medical Res Council filed Critical Medical Res Council
Application granted granted Critical
Publication of ATE103294T1 publication Critical patent/ATE103294T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT90308662T 1989-08-09 1990-08-07 Peptidfragmente von hiv. ATE103294T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898918200A GB8918200D0 (en) 1989-08-09 1989-08-09 The peptide fragments of hiv
EP90308662A EP0412766B1 (de) 1989-08-09 1990-08-07 Peptidfragmente von HIV

Publications (1)

Publication Number Publication Date
ATE103294T1 true ATE103294T1 (de) 1994-04-15

Family

ID=43806939

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90308662T ATE103294T1 (de) 1989-08-09 1990-08-07 Peptidfragmente von hiv.

Country Status (12)

Country Link
US (1) US5700635A (de)
EP (1) EP0412766B1 (de)
JP (1) JPH04507100A (de)
AT (1) ATE103294T1 (de)
CA (1) CA2064691A1 (de)
DE (1) DE69007571T2 (de)
DK (1) DK0412766T3 (de)
ES (1) ES2054256T3 (de)
GB (2) GB8918200D0 (de)
HK (1) HK141494A (de)
SG (1) SG130094G (de)
WO (1) WO1991001996A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128319A (en) 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
GB2220939B (en) * 1988-06-10 1992-02-26 Medical Res Council Peptide fragments of hiv and their use in vaccines and diagnosis
WO1991009869A1 (en) * 1990-01-05 1991-07-11 Medical Research Council Hiv-1 core protein fragments
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
WO1995011255A1 (en) * 1993-10-19 1995-04-27 Ajinomoto Co., Inc. Peptide capable of inducing immune response against hiv and aids preventive or remedy containing the peptide
GB9426153D0 (en) * 1994-12-23 1995-02-22 Medical Res Council Improvements in or relating to vaccines
DE60043856D1 (de) * 1999-12-23 2010-04-01 Medical Res Council Verbesserungen in oder in bezug auf immunantworten gegen hiv
CU23235A1 (es) * 2001-02-28 2007-09-26 Ct Ingenieria Genetica Biotech POXVIRUS RECOMBINANTES PARA PROTEINAS QUIMéRICAS DEL VIRUS DE LA INMUNODEFICIENCIA HUMANA Y SU APLICACION EN LA TERAPéUTICA Y LA PREVENCION DEL SIDA
NZ607536A (en) * 2008-04-24 2014-08-29 Avery Dennison Corp Sheet having removable labels and related method
EP2620446A1 (de) 2012-01-27 2013-07-31 Laboratorios Del Dr. Esteve, S.A. Immunogene zur HIV-Impfung
AU2020384323A1 (en) 2019-11-14 2022-06-02 Aelix Therapeutics, S.L. Dosage regimens for vaccines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6713287A (en) * 1986-01-06 1987-07-09 F. Hoffmann-La Roche & Co. Expression of htlv-iii gag-gene
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
EP0330359A3 (de) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion

Also Published As

Publication number Publication date
HK141494A (en) 1994-12-23
GB8918200D0 (en) 1989-09-20
ES2054256T3 (es) 1994-08-01
DE69007571D1 (de) 1994-04-28
EP0412766B1 (de) 1994-03-23
GB2250994A (en) 1992-06-24
SG130094G (en) 1995-01-13
DK0412766T3 (da) 1994-07-18
GB9201468D0 (en) 1992-04-01
GB2250994B (en) 1993-08-25
CA2064691A1 (en) 1991-02-10
JPH04507100A (ja) 1992-12-10
EP0412766A1 (de) 1991-02-13
WO1991001996A1 (en) 1991-02-21
DE69007571T2 (de) 1994-09-08
US5700635A (en) 1997-12-23

Similar Documents

Publication Publication Date Title
GB2255093A (en) Hiv-1 core protein fragments
DE3588254D1 (de) Gag-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
ATE127345T1 (de) Stressproteine und verwendungen dafür.
ATE188612T1 (de) Konjugate von schwach immunogenen antigenen und synthetischen peptidträgern und impfstoffe diese enthaltend
ATE103294T1 (de) Peptidfragmente von hiv.
DE68925660D1 (de) Peptidfragmente von HIV
WO1989002277A3 (en) Prophylaxis and therapy of acquired immunodeficiency syndrome
DK0491628T3 (da) Lipopeptider inducerende cytotoksiske T-lymfocytter og deres anvendelse som vacciner
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
ES2071038T3 (es) Peptidos asociados al hiv.
NZ224251A (en) Synthetic rhinovirus (hrv) peptides and vaccines
ATE111485T1 (de) Peptidbehandlung von hartnäckigen infektionskrankheiten.
ES2061944T3 (es) Conjugado de peptido inmunologicamente activo ppd (nanp)n util como vacuna antimalaria.
MY106940A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee
RZN Patent revoked